MR-guided laser ablation proved as effective as surgery, the current standard of care, for the treatment of liver tumors in a study by University of Frankfurt researchers. The trial highlights the largest patient population and longest follow-up of its kind.
MR-guided laser ablation proved as effective as surgery, the current standard of care, for the treatment of liver tumors in a study by University of Frankfurt researchers. The trial highlights the largest patient population and longest follow-up of its kind.
Dr. Martin Mack and colleagues treated 2506 liver tumors with MR-guided laser-induced thermotherapy (LITT) between 1993 and 2005. They tracked patients' survival rates to evaluate the long-term effectiveness of the procedure.
The average survival rate of 3.8 years for patients treated with LITT compared favorably with that of surgery, which yielded a survival rate of approximately 1.5 to five years. Mack presented the findings at the 2005 RSNA meeting.
Interventionalists can offer LITT on an outpatient basis under local anesthesia. Patients spend only a few hours instead of weeks in the hospital after resection. Physicians can perform LITT simultaneously on both liver lobes and repeat treatment if they find new tumors at follow-up, which is virtually impossible by traditional surgical means, Mack said. He concluded that LITT is superior to resection in surgical candidates.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.